Are you Dr. Kern?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Crb1 Rm 451
1650 Orleans St
Baltimore, MD 21287Phone+1 410-514-3314Fax+1 443-287-4653
Summary
- Dr. Scott Kern, MD is a board certified pathologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Michigan. He is a Professor of Oncology at Johns Hopkins University School of Medicine.
Education & Training
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1987 - 1988
University of MichiganResidency, Pathology-Anatomic and Clinical, 1983 - 1986
University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
MD State Medical License 1987 - 2026
MI State Medical License 1984 - 1988- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 171 citationsAllelotype of Pancreatic AdenocarcinomaA. B. Seymour, Ralph H. Hruban, Mark Redston, Carlos Caldas, Steve M. Powell
Cancer Research. 1994-05-15 - 108 citationsK-ras mutation and pancreatic adenocarcinoma.Carlos Caldas, Scott E. Kern
International Journal of Pancreatology. 1995-08-01 - 443 citationsLoss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.Robb E. Wilentz, Christine A. Iacobuzio-Donahue, Pedram Argani, Denis M. McCarthy, Jennifer Parsons
Cancer Research. 2000-04-01
Press Mentions
Local Car Club Chapter Raises $5800 for First RespondersMay 27th, 2021
Compounds in Saliva, Common Body Proteins May Fend off DNA-Damaging Chemicals in Tea, Coffee and Liquid SmokeMay 30th, 2014- Cancer Biologists Find DNA-Damaging Toxins in Common Plant-Based FoodsMarch 27th, 2013
- Join now to see all
Grant Support
- Discovery And Evaluation Of Prioritized Mutations In Pancreatic CancerNational Cancer Institute2009–2012
- High-Throughput Analysis Of Pancreatic Cancer MutationsNational Cancer Institute2009–2011
- Fanconi Defects In Pancreatic Cancer OncogenesisNational Cancer Institute2008–2011
- Pharmacodiagnotics Through Molecular CluesNational Cancer Institute2007–2011
- Career Development ProgramNational Cancer Institute2007–2011
- Administration And Communication CoreNational Cancer Institute2007–2011
- Spore In Gastrointestinal CancerNational Cancer Institute1999–2011
- Supplement: Screening For Early Pancreatic Neoplasia: A Multi-Center StudyNational Cancer Institute2007
- DPC4, Target Of 18q Deletion In Pancreatic CancerNational Cancer Institute2002–2006
- Spore In Gastrointestinal CancerNational Cancer Institute2002–2006
- New Genetic Clues For Pancreatic CancerNational Cancer Institute2002
- Components Of Early And LATE Pancreatic NeoplasiaNational Cancer Institute2002
- Targets For Screening In Pancreatic NeoplasiaNational Cancer Institute1997–2002
- New Genetic Markers For Pancreatic CancerNational Cancer Institute1997–2002
- DPC4 Target Of 18q Homozygous Deletions In Pancreatic CANational Cancer Institute1997–2001
- Genetic Alterations In Pancreatic Carcinoma And PrecursorsNational Cancer Institute1996
